Study | Plasma sample (n) | Diagnosis | Pro-ANP | ANP | Pro-ANP/ANP |
Thesis et al13 | 1 | Normal control | None | Major | |
Akiba et al18 | 25 | Normal control | Minor | Major | |
Hunter et al12 | 10, Pooled plasma | Normal control | Equal | Equal | |
Ohashi et al39 | 1 | Normal control | None | Present | |
Sato et al40 | 7, Pooled plasma | Normal control | Minor | Major | |
Meleagros et al19 | 1 | Normal control | Minor | Major | 0.24 |
Ando et al21 | 1 | Normal control | Minor | Major | |
Tan et al41 | 2 | Normal control | Minor | Major | |
Espiner et al42 | 1 | Normal control | Minor | Major | |
Azizi et al22 | Pooled plasma | Normal control | Minor | Major | |
Yamaji et al14 | 1 | Normal heart, pregnant woman | Minor | Major | |
Predel et al43 | 4 | CRF, normotension | Minor | Major | 0.25 |
Ishizaka et al15 | 1 | HD, normal heart | Minor | Major | 0.47 |
Cannella et al16 | 10, pooled | HD, normal heart | Minor | Major | |
Akiba et al18 | 10 | HD, normal heart | Minor | Major | |
Hasegawa et al17 | 1 | HD, normal heart | Minor | Major | |
Lindberg et al44 | 2 | HD, MV stenosis; HD, MI | Minor | Major | |
Hunter et al12 | 7, Pooled plasma | HF | Equal | Equal | Pro-ANP=ANP |
Yamaji et al14 | 3, Pooled plasma | HF | Minor | Major | |
Meleagros et al19 | 1 | HF | Minor | Major | 0.16 |
Mukoyama et al11 | 1 | HF | Minor | Major | Pro-ANP<<ANP |
Ando et al21 | 4 | NYHA class I | Minor | Major | 0.087 |
11 | NYHA class II | Minor | Major | 0.45 | |
5 | NYHA class III | Major | Minor | 1.63 | |
8 | NYHA class IV | Major | Minor | 1.27 | |
Azizi et al22 | Pooled plasma | HF | Major | Minor | Pro-ANP>>ANP |
ANP, atrial natriuretic peptide; CRF, chronic renal failure; HD, haemodialysis; HF, heart failure; Ir, immunoreactive; MI, myocardial infarction; MV, mitral valve; NYHA, New York Heart Association.